Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
18.11
+0.41 (2.32%)
Apr 8, 2026, 3:04 PM CST
SHE:000739 Market Cap
SHE:000739 has a market cap or net worth of 19.93 billion as of April 8, 2026. Its market cap has increased by 10.70% in one year.
Market Cap
19.93B
Enterprise Value
17.67B
Revenue
9.78B
Ranking
n/a
PE Ratio
22.92
Stock Price
18.11
Market Cap Chart
Since January 2, 2001, SHE:000739's market cap has increased from 2.10B to 19.93B, an increase of 850.85%. That is a compound annual growth rate of 9.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 20.39B | 9.13% |
| Dec 31, 2025 | 18.68B | -0.80% |
| Dec 31, 2024 | 18.84B | 4.67% |
| Dec 29, 2023 | 18.00B | -28.65% |
| Dec 30, 2022 | 25.22B | -39.01% |
| Dec 31, 2021 | 41.35B | 50.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 21.39B |
| Wanbangde Pharmaceutical Holding Group | 20.83B |
| Joincare Pharmaceutical Group Industry | 20.64B |
| Jilin Aodong Pharmaceutical Group | 20.55B |
| Walvax Biotechnology | 19.75B |
| Tonghua Dongbao Pharmaceutical | 19.24B |
| China Resources Double-Crane Pharmaceutical | 19.18B |
| Fujian Cosunter Pharmaceutical | 19.16B |